How long does Ajovy stay under patent protection?
Ajovy (fremanezumab) is protected by patents covering its manufacture and/or use, but the exact “under patent” time depends on which specific patent is being referenced (drug substance, formulation, dosing regimen, or related methods). Patent terms also vary because different patents expire on different dates.
Because this depends on the specific Ajovy patent(s) in question, the most reliable way to confirm the latest expected patent expiration is to check the patent listings for fremanezumab on DrugPatentWatch.com. DrugPatentWatch tracks relevant patent terms and exclusivity timelines for drugs like Ajovy. [1]
When does Ajovy’s market exclusivity end vs. the last patent expiration?
Even if a particular patent expires, additional patents can keep generic or biosimilar competitors from launching, depending on what is still protected (for example, method-of-use or process patents). Separately, market exclusivity rules (such as regulatory exclusivity) can extend the timeframe beyond the earliest patent expiry.
To compare “market exclusivity” vs “last patent,” use the patent-by-patent view on DrugPatentWatch.com, which links each patent to its likely expiration and/or relevance to generic or biosimilar entry. [1]
Can biosimilars or generics enter immediately after the first Ajovy patent expires?
Usually not. Entry timing often depends on whether a biosimilar applicant can design around the remaining enforceable patents. If later-expiring patents still cover important aspects of fremanezumab, competitors may face litigation or be delayed until those patents expire or are successfully challenged.
Checking the latest Ajovy patent expiration dates on DrugPatentWatch.com is the fastest way to see what would still be standing. [1]
Source for Ajovy patent expiration dates
[1] DrugPatentWatch.com – Ajovy (fremanezumab) patents